Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.
Clin Immunol. 2020 Jun;215:108409. doi: 10.1016/j.clim.2020.108409. Epub 2020 Apr 7.
It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.
这是一个残酷的事实,在当前的传播情况下,世界上相当一部分人口将感染 SARS-CoV-2。虽然目前还没有特效治疗方法,但个体风险评估和管理策略至关重要。个体预防和保护措施决定了个体患病的风险。在感染病毒的宿主中,他们的不同代谢状态,由他们的饮食、营养、年龄、性别、医疗状况、生活方式和环境因素决定,决定了他们在 COVID-19 不同临床严重程度上的个人命运,从无症状、轻症、中度到死亡。仔细评估个体可能存在的饮食、营养、医疗、生活方式和环境风险,并采取适当的相关风险管理策略,是应对 SARS-CoV-2 大流行的明智方法。
Clin Chim Acta. 2020-5-29
Virus Res. 2020-8-13
J Med Virol. 2020-6
Tunis Med. 2020-4
Adv Biol Regul. 2020-8
Med J Malaysia. 2020-5
J Zhejiang Univ Sci B. 2020-5-8
Int J Environ Res Public Health. 2025-1-22
Tohoku J Exp Med. 2020-7
Cureus. 2020-3-18
Tob Induc Dis. 2020-3-20
Nat Biotechnol. 2020-4